<DOC>
	<DOCNO>NCT01128322</DOCNO>
	<brief_summary>The aim trial determine best dose combination S-Amlodipine Telmisartan compare monotherapy assess blood pressure lower effect daily regimen various combination S-Amlodipine Telmisartan , compare monotherapy component placebo , patient stage I II essential hypertension ( mean seat cuff diastolic blood pressure &gt; =95 &lt; =115 mmHg ) .</brief_summary>
	<brief_title>CKD-828 Primary Hypertension Trial ( Dose-selection )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>age 18 year old stage I II hypertension define : mean seat cuff diastolic blood pressure &gt; =95 &lt; =115 mmHg ability provide write informed consent severe hypertension define : mean seat cuff diastolic blood pressure &gt; =116mmHg mean seat cuff systolic blood pressure &gt; =200mmHg know suspect secondary hypertension ( ex . aortic coarctation , Primary hyperaldosteronism , renal artery stenosis , pheochromocytoma ) severe heart disease ( Heart failure NYHA functional class 3 , 4 ) , unstable angina myocardial infarction , arrhythmia within past three month cerebrovascular disease cerebral infarction , cerebral hemorrhage within 6 month Type I Diabets Mellitus , Type II Diabetes Mellitus poor glucose control define fast glucosylated hemoglobin ( HbA1c ) &gt; 8 % know severe malignant retinopathy hepatic renal dysfunction define follow laboratory parameter : AST/ALT &gt; UNL X 2 , serum creatinine &gt; UNL X 1.5 acute chronic inflammatory status need treatment need additional antihypertensive drug study need concomitant medication know affect blood pressure study history angioedema related ACE inhibitor Angiotensin II Receptor Blockers know hypersensitivity relate either study drug history drug alcohol dependency surgical medical condition might significantly alter absorption , distribution , metabolism , excretion investigational product ( ex . gastrointestinal tract surgery gastrectomy , gastroenterostomy bypass , active inflammatory bowel syndrome within 12 month prior screen , currently active gatritis , ulcer gastrointetinal/rectal bleeding , impaired pancreatic fuction pancreatitis , obstruction urinary tract difficulty void ) swallow investigational product administration study drug within 4 week prior randomization premenopausal woman ( last menstration &lt; 1year ) use adequte contraception , pregnant breastfeed history malignancy include leukemia lymphoma within past 5 year investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>CKD-828</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Primary Hypertension</keyword>
	<keyword>S-Amlodipine</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Factorial</keyword>
	<keyword>Phase 2</keyword>
</DOC>